$DORM
Dorman Products, Inc.

2022 Q4 Form 10-Q Financial Statement

#000156459022034964 Filed on October 24, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $501.3M $413.5M
YoY Change 25.89% 18.67%
Cost Of Revenue $343.5M $281.6M
YoY Change 28.77% 21.59%
Gross Profit $157.8M $131.9M
YoY Change 20.06% 12.89%
Gross Profit Margin 31.47% 31.9%
Selling, General & Admin $125.0M $89.81M
YoY Change 44.82% 23.6%
% of Gross Profit 79.23% 68.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.55M $11.53M
YoY Change 32.0% 42.69%
% of Gross Profit 8.59% 8.74%
Operating Expenses $125.0M $89.81M
YoY Change 44.82% 23.6%
Operating Profit $32.77M $42.10M
YoY Change -27.34% -4.74%
Interest Expense -$10.44M $2.344M
YoY Change 739.39% -419.78%
% of Operating Profit -31.86% 5.57%
Other Income/Expense, Net $605.0K -$65.00K
YoY Change 1306.98% -168.42%
Pretax Income $22.94M $39.69M
YoY Change -47.76% -8.87%
Income Tax $5.099M $9.087M
% Of Pretax Income 22.23% 22.9%
Net Earnings $17.84M $30.60M
YoY Change -47.66% -7.56%
Net Earnings / Revenue 3.56% 7.4%
Basic Earnings Per Share $0.97
Diluted Earnings Per Share $0.57 $0.97
COMMON SHARES
Basic Shares Outstanding 31.42M 31.43M
Diluted Shares Outstanding 31.55M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.03M $35.44M
YoY Change -21.69% -38.12%
Cash & Equivalents $46.03M $35.44M
Short-Term Investments
Other Short-Term Assets $39.80M $30.46M
YoY Change 205.03% 76.08%
Inventory $755.9M $677.9M
Prepaid Expenses
Receivables $427.4M $433.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.269B $1.177B
YoY Change 17.88% 16.18%
LONG-TERM ASSETS
Property, Plant & Equipment $148.5M $122.1M
YoY Change 29.26% 4.98%
Goodwill $443.0M $195.7M
YoY Change 124.51% -2.15%
Intangibles $322.4M $169.0M
YoY Change 80.31% -7.54%
Long-Term Investments $9.400M
YoY Change 0.0%
Other Assets $48.77M $44.87M
YoY Change 4.87% -2.14%
Total Long-Term Assets $1.073B $624.2M
YoY Change 79.82% 3.56%
TOTAL ASSETS
Total Short-Term Assets $1.269B $1.177B
Total Long-Term Assets $1.073B $624.2M
Total Assets $2.342B $1.801B
YoY Change 39.97% 11.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $179.8M $199.2M
YoY Change 1.37% 32.85%
Accrued Expenses $246.6M $245.3M
YoY Change -0.68% 9.78%
Deferred Revenue
YoY Change
Short-Term Debt $239.4M $229.4M
YoY Change 0.0% -8.02%
Long-Term Debt Due $12.50M
YoY Change
Total Short-Term Liabilities $678.3M $673.9M
YoY Change 1.99% 8.21%
LONG-TERM LIABILITIES
Long-Term Debt $482.5M $0.00
YoY Change
Other Long-Term Liabilities $28.35M $5.159M
YoY Change 476.67% 9.63%
Total Long-Term Liabilities $510.8M $5.159M
YoY Change 10290.83% 9.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $678.3M $673.9M
Total Long-Term Liabilities $510.8M $5.159M
Total Liabilities $1.189B $679.0M
YoY Change 77.49% 8.22%
SHAREHOLDERS EQUITY
Retained Earnings $956.9M $939.2M
YoY Change 11.73% 13.04%
Common Stock $89.06M $85.69M
YoY Change 14.53% 16.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.043B $1.021B
YoY Change
Total Liabilities & Shareholders Equity $2.342B $1.801B
YoY Change 39.97% 11.47%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $17.84M $30.60M
YoY Change -47.66% -7.56%
Depreciation, Depletion And Amortization $13.55M $11.53M
YoY Change 32.0% 42.69%
Cash From Operating Activities $12.34M -$8.042M
YoY Change -45.71% -120.88%
INVESTING ACTIVITIES
Capital Expenditures $14.10M -$7.680M
YoY Change -408.87% 49.97%
Acquisitions
YoY Change
Other Investing Activities -$489.6M $0.00
YoY Change -100.0%
Cash From Investing Activities -$503.7M -$7.680M
YoY Change 10930.53% -97.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 501.9M -723.0K
YoY Change -3119.89% -100.34%
NET CHANGE
Cash From Operating Activities 12.34M -8.042M
Cash From Investing Activities -503.7M -7.680M
Cash From Financing Activities 501.9M -723.0K
Net Change In Cash 10.60M -16.44M
YoY Change 583.17% -83.26%
FREE CASH FLOW
Cash From Operating Activities $12.34M -$8.042M
Capital Expenditures $14.10M -$7.680M
Free Cash Flow -$1.759M -$362.0K
YoY Change -106.44% -100.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30456000
CY2022Q3 us-gaap Assets
Assets
1801208000
CY2021Q4 us-gaap Assets
Assets
1673119000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1021041000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29344000
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000868780
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-24
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-18914
dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2078856
dei Entity Address Address Line1
EntityAddressAddressLine1
3400 East Walnut Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Colmar
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
18915
dei City Area Code
CityAreaCode
215
dei Local Phone Number
LocalPhoneNumber
997-1800
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
DORM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31418575
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413470000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
348426000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1232468000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
947073000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
281559000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
231572000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
825792000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
615574000
CY2022Q3 us-gaap Gross Profit
GrossProfit
131911000
CY2021Q3 us-gaap Gross Profit
GrossProfit
116854000
us-gaap Gross Profit
GrossProfit
406676000
us-gaap Gross Profit
GrossProfit
331499000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89814000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72663000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
268400000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
205049000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
42097000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
44191000
us-gaap Operating Income Loss
OperatingIncomeLoss
138276000
us-gaap Operating Income Loss
OperatingIncomeLoss
126450000
CY2022Q3 us-gaap Interest Expense
InterestExpense
2344000
CY2021Q3 us-gaap Interest Expense
InterestExpense
733000
us-gaap Interest Expense
InterestExpense
5140000
us-gaap Interest Expense
InterestExpense
918000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-65000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
95000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
130000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
334000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39688000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
43553000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
133266000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
125866000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9087000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10449000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29553000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28414000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
30601000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
33104000
us-gaap Net Income Loss
NetIncomeLoss
103713000
us-gaap Net Income Loss
NetIncomeLoss
97452000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2112000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2415000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28489000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33104000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
101298000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
97452000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.04
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31411000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31692000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31444000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31895000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31545000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31842000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31561000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32039000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35435000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58782000
CY2022Q3 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1388000
CY2021Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1326000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
433229000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
472764000
CY2022Q3 us-gaap Inventory Net
InventoryNet
677898000
CY2021Q4 us-gaap Inventory Net
InventoryNet
531988000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13048000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1177018000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1076582000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122106000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114864000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
92440000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59029000
CY2022Q3 us-gaap Goodwill
Goodwill
195725000
CY2021Q4 us-gaap Goodwill
Goodwill
197332000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
169046000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
178809000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44873000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
46503000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
199180000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
177389000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15523000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26636000
CY2022Q3 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
199779000
CY2021Q4 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
188080000
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
229360000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
239360000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30036000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33583000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
673878000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
665048000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
83983000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52443000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5159000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4916000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
17147000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
17976000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31419392
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31419392
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31607509
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31607509
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
314000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
316000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
85374000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
77451000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
939208000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
856409000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3855000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1440000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
932736000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1801208000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1673119000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
990957000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2472000
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1522000
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
812000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-181000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2112000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
30601000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1021041000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
892985000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
173000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1721000
CY2021Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
23364000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-95000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
33104000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
904524000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
932736000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
971000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6742000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
19717000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1189000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-2178000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2415000
us-gaap Net Income Loss
NetIncomeLoss
103713000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1021041000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
853559000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
909000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6212000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
54613000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2493000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1488000
us-gaap Net Income Loss
NetIncomeLoss
97452000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
904524000
us-gaap Profit Loss
ProfitLoss
103713000
us-gaap Profit Loss
ProfitLoss
97452000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
31131000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
24931000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
80000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
61000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-546000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-414000
us-gaap Share Based Compensation
ShareBasedCompensation
6742000
us-gaap Share Based Compensation
ShareBasedCompensation
6212000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
2418000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39325000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20746000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
146278000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
97156000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7228000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7216000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-157000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3639000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
17887000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
20456000
dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
11712000
dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
23786000
dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
-27351000
dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
-5200000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
77601000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-595000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
345483000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23780000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15274000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23185000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-360757000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
252360000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3000000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7982000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4215000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
971000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
909000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
19717000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
54272000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-664000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
1055000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29410000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
184855000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-96000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-12000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23347000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-98313000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58782000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
155576000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35435000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57263000
us-gaap Interest Paid Net
InterestPaidNet
4366000
us-gaap Interest Paid Net
InterestPaidNet
567000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
49670000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
37500000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
371408000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1070238000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
37089000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
108016000
CY2021Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.16
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
3.37
CY2022Q3 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
240000000.0
CY2021Q3 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
256300000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
778100000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
690000000.0
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
193845000
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
16407000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
12746000
CY2022Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
251778000
CY2021Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
225879000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
400456000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
287415000
CY2022Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
9257000
CY2021Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
5948000
CY2022Q3 us-gaap Inventory Net
InventoryNet
677898000
CY2021Q4 us-gaap Inventory Net
InventoryNet
531988000
CY2021Q4 us-gaap Goodwill
Goodwill
197332000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1607000
CY2022Q3 us-gaap Goodwill
Goodwill
195725000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24799000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
169046000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194807000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15998000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178809000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000.0
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
77.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
78574
us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
3600000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1600000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1600000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1600000
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P1Y
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413470000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
348426000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1232468000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
947073000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413470000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
348426000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1232468000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
947073000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
117000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
144000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31545000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31842000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
206677
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
85.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
100517
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
100.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
53569
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
83.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
40002
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
83.51
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
213623
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
93.97
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
500000
CY2021Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1300000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
900000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
233396
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
97.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11236
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
77.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
663
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
101.45
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31141
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
71.78
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
268930
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
84.16
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1793436000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
95927
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
76.08
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
929436000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
30601000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
33104000
us-gaap Net Income Loss
NetIncomeLoss
103713000
us-gaap Net Income Loss
NetIncomeLoss
97452000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31411000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31692000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31444000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31895000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
134000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
150000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31561000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32039000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.04
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1400000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2300000
dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01

Files In Submission

Name View Source Status
0001564590-22-034964-index-headers.html Edgar Link pending
0001564590-22-034964-index.html Edgar Link pending
0001564590-22-034964.txt Edgar Link pending
0001564590-22-034964-xbrl.zip Edgar Link pending
dorm-10q_20220924.htm Edgar Link pending
dorm-20220924.xsd Edgar Link pending
dorm-ex311_7.htm Edgar Link pending
dorm-ex312_8.htm Edgar Link pending
dorm-ex32_6.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gg22vbiinn4i000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
dorm-20220924_cal.xml Edgar Link unprocessable
dorm-20220924_def.xml Edgar Link unprocessable
dorm-20220924_lab.xml Edgar Link unprocessable
dorm-10q_20220924_htm.xml Edgar Link completed
dorm-20220924_pre.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable